Najdzel Faradz je to vrlo lepo opisao u jednom intervjuu, kaze novinaru odprilike ovako "vidite li ovu hrpu papira (pokazuje rukom na gomilu papira i fascikli), tu ima nekoliko hiljada stranica zakona koje treba da usvojimo u parlamentu, to treba da uradimo do sutra ujutru, a dobili smo papire juce posle podne, da li mislite da je neko od nas (misleci na poslanike) to procitao? " : )

To je tipican primer kako stvari funkcionisu, EU (ako pricamo o EU, mada citav "zapadni svet" je manje vise takav, sa pojedinacnim oazama slobode) je jedna velika, glomazna, birokratska, profasiticka struktura, korporativnog karaktera, koja ima za cilj dalju centralizaciju moci.

Oni sve znaju ...samo ne znaju ono sto treba...

I tako 

Ukratko: lek je koštao $13.50 sad je kupio prava na taj lek i košta $750


This Guy Just Raised The Cost Of An HIV Drug By 5000%




Daraprim is used to fight a parasitic infection called toxoplasmosis, which is potentially life-threatening for people with weakened immune systems, such as those with AIDS or cancer. But just last month, the price shot up more than 5,000%, from $13.50 (£8.70) a tablet to $750 (£485) per pill, USA Today reported last week. That means the annual cost of the treatment could be hundreds of thousands of dollars.

Toxoplasmosis is a leading cause of death by a foodborne illness in the U.S., according to the Centers for Disease Control and Prevention. The single-celled parasite Toxoplasma gondii infects most animals, though it only reproduces in cats. People become infected by consuming contaminated water or meat and unwashed fruits and vegetables, using contaminated knives and cutting boards, and coming into contact with the feces of infected cats. More than 60 million Americans carry the parasite yet very few show symptoms thanks to their immune systems. However, babies born to women infected while pregnant and anyone with a compromised immune system could suffer severe consequences: The parasite attacks the brain and can lead to seizures, blindness, or neurological damage.
 
Daraprim (which is the trade name for pyrimethamine) has been approved by the U.S. Food and Drug Administration since 1953. For decades, it was made by GlaxoSmithKline, which sold the U.S. marketing rights in 2010 to CorePharma, which was bought by Impax Laboratories last year. This latest price spike came last month, shortly after New York-based Turing Pharmaceuticals purchased exclusive rights to the drug.

The price increase could force hospitals to use alternative therapies without the same efficacy, The New York Times explained, and because of the price tag attached to “specialty” drugs, even patients with insurance might not be able to afford Daraprim.

In a joint letter to Turing earlier this month, the Infectious Diseases Society of America and the HIV Medicine Association urged the company to revise its pricing strategy: “This cost is unjustifiable for the medically vulnerable patient population in need of this medication and unsustainable for the health care system.” The annual cost of treating toxoplasmosis could be as much as $634,500, they calculated.   

According to Turing founder and chief executive, Martin Shkreli, the company plans to use the money to develop better treatments for toxoplasmosis. He also said the drug is so rarely used, the impact on the health system would be minuscule. “This isn’t the greedy drug company trying to gouge patients,” Shkreli told The New York Times, “it is us trying to stay in business.” Turing spokesman Craig Rothenberg told USA Today that the company is working with hospitals and providers to get every patient covered, from free-of-charge options for uninsured patients to co-pay assistance programs, adding that “there has been no innovation in dealing with toxoplasmosis.”

Until last month, the Los Angeles Times reported, the six-week, two-pill-a-day course of Daraprim would have cost just $1,130.

Ušće

Da taman sam hteo da napisem...55 puta poskupelo...

  Tip je albanjesku,što pojašnjava nivo empatije koji je pokazao (između ostalog i u sopstvenim besnim tvitovima) . Stvar je u tome što nije učinio ništa što već nije postalo trend među tek ispilelim japijima.Barem je dobio i stranicu na Vikipediji :

     https://en.wikipedia.org/wiki/Martin_Shkreli

     http://wayback.archive.org/web/20130122145045/http://botasot.info/diaspora/204086/shqiptaro-amerikani-anetar-i-revistes-forbes-finance-quot-30-under-30-quot/

 

Ajd nishta sekiracija, u sledecih mesec/dva ce se pojaviti lek koji ce koshtati $300 dolara, i alternativni preparat koji ce koshtati $200...

Farmaceuti isplatili lani liječnicima 6,5 mlrd. dolara

Predvodnik je švicarski Roche s isplaćenih 435 mil. dolara, a slijedi ga Novartis s 300 mil. dolara i Sanofi s 215 mil. dolara.

Dio novca odlazi bolnicama za klinička ispitivanja/REUTERS

Europske farmaceutske kompanije na vrhu su liste najvećih isplatitelja novca liječnicima i bolnicama čime se još jednom potvrđuje snažna veza između farmaceuta i medicinskog establišmenta.

Prema službenim statistikama koje traži američki zakon kako bi se transparentno prikazalo koliko farmaceuti plaćaju liječnike, najveće europske kompanije samo su američkim liječnicima prošle godine isplatile 1,5 milijardi dolara i bolnicama. Na globalnoj razini lani se u liječničke džepove slilo 6,5 milijardi dolara farmaceutskog novca. Europski farmaceuti isplatili su 23 posto tog novca, prenosi Financial Times. Inače, kompanije liječnike isplaćuju za konzultantske usluge, putne troškove ili honoriraju njihove govore prilikom predstavljanja novih lijekova.

Bolnice dobivaju naknade za klinička ispitivanja lijekova. Na listi najvećih isplatitelja predvodi švicarski Roche koji je liječnicima isplatio 435 milijuna dolara. To je više nego što je isplatila bilo koja američka kompanija, uključujući divove poput Pfizera i Mercka. Roche je pojasnio kako je 250 milijuna dolara otišlo kalifornijskoj bolnici City of Hope koja drži patentna prava na njihove uspješne lijekove protiv karcinoma, Avastin i Herceptin te lijek za multipla sklerozu Rituxan. Roche slijedi Novartis, također švicarska kompanija, koja je isplatila malo više od 300 milijuna dolara.

 Na trećem je mjestu francuski Sanofi s 215 milijuna dolara dok je na četvrtom mjestu britanski GlaxoSmithKline s neznatno manjih 213 milijuna dolara. Na petom je mjestu također britanska AstraZeneca sa 184 milijuna dolara. AstraZeneca je 74 milijuna dolara utrošila za neistraživačke svrhe, a britanskom je mediji odgovorila kako "pacijentima ultimativno koristi kada su liječnici dobro informirani i upoznati s našim lijekovima". 

http://www.poslovni.hr/svijet-i-regija/farmaceuti-isplatili-lani-lijecnicima-65-mlrd-dolara-298579

..........................................................

"Roche je pojasnio kako je 250 milijuna dolara otišlo"  ... ali pazite - otislo. Kao da kupuju litar rakije kod seljaka : )))

Oni moraju da rade, da zive, da brinu o svojim porodicama, da placaju racune svakog meseca, da svojim radom i zaslugama dorpinose zajednici!!!1 I oni su ljudi, rade za platu.
Позз!!1389

Film Saše Kneževa "Američka zavisnost":

"American Addict unveils how America has gone from the land of the free to the land of the addicted.
America represents 5% of the world’s population but consumes 50% of the world’s prescription pills and over 80% of the world’s prescription narcotics; this is NOT a coincidence. This film reveals the relationships between the FDA, big Pharma, physicians and the media that are in place to ensure that medical problems are treated primarily with pills. The horrific consequences that result from this practice results in overuse, abuse and unnecessary deaths. American Addict is the most important film of 2013 because it could literally save your or a loved one’s life."
http://www.rt.com/shows/documentary/258565-american-addict-drugs-pills/


American Addict 2: The Big Lie (http://www.imdb.com/title/tt4219652/)



"We did not have school shooting before these drugs."


American Addict (2012)  (http://www.imdb.com/title/tt2281095/?ref_=tt_rec_tt)

..............................................................................

Ma jebo to, daj da pravimo pare брте  xe xe

U ostatku sveta kosta 10$


Glupi Ameri...